166 related articles for article (PubMed ID: 38153903)
1. Targeting of the CD161 inhibitory receptor enhances T-cell-mediated immunity against hematological malignancies.
Alvarez Calderon F; Kang BH; Kyrysyuk O; Zheng S; Wang H; Mathewson ND; Luoma AM; Ning X; Pyrdol J; Cao X; Suvà ML; Yuan GC; Wittrup KD; Wucherpfennig KW
Blood; 2024 Mar; 143(12):1124-1138. PubMed ID: 38153903
[TBL] [Abstract][Full Text] [Related]
2. The c.503T>C Polymorphism in the Human KLRB1 Gene Alters Ligand Binding and Inhibitory Potential of CD161 Molecules.
Rother S; Hundrieser J; Pokoyski C; Kollrich S; Borns K; Blasczyk R; Poehnert D; Klempnauer J; Schwinzer R
PLoS One; 2015; 10(8):e0135682. PubMed ID: 26309225
[TBL] [Abstract][Full Text] [Related]
3. CD161 expression and regulation defines rapidly responding effector CD4+ T cells associated with improved survival in HPV16-associated tumors.
Duurland CL; Santegoets SJ; Abdulrahman Z; Loof NM; Sturm G; Wesselink TH; Arens R; Boekestijn S; Ehsan I; van Poelgeest MIE; Finotello F; Hackl H; Trajanoski Z; Ten Dijke P; Braud VM; Welters MJP; van der Burg SH
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35039463
[TBL] [Abstract][Full Text] [Related]
4. Increased frequency of CD4+ cells expressing CD161 in cancer patients.
Iliopoulou EG; Karamouzis MV; Missitzis I; Ardavanis A; Sotiriadou NN; Baxevanis CN; Rigatos G; Papamichail M; Perez SA
Clin Cancer Res; 2006 Dec; 12(23):6901-9. PubMed ID: 17145807
[TBL] [Abstract][Full Text] [Related]
5. C-type lectin-like CD161 is not a co-signalling receptor in gluten-reactive CD4 + T cells.
Wyrożemski Ł; Sollid LM; Qiao SW
Scand J Immunol; 2021 Jun; 93(6):e13016. PubMed ID: 33368526
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis.
Mathewson ND; Ashenberg O; Tirosh I; Gritsch S; Perez EM; Marx S; Jerby-Arnon L; Chanoch-Myers R; Hara T; Richman AR; Ito Y; Pyrdol J; Friedrich M; Schumann K; Poitras MJ; Gokhale PC; Gonzalez Castro LN; Shore ME; Hebert CM; Shaw B; Cahill HL; Drummond M; Zhang W; Olawoyin O; Wakimoto H; Rozenblatt-Rosen O; Brastianos PK; Liu XS; Jones PS; Cahill DP; Frosch MP; Louis DN; Freeman GJ; Ligon KL; Marson A; Chiocca EA; Reardon DA; Regev A; Suvà ML; Wucherpfennig KW
Cell; 2021 Mar; 184(5):1281-1298.e26. PubMed ID: 33592174
[TBL] [Abstract][Full Text] [Related]
7. A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint.
Zhou X; Du J; Liu C; Zeng H; Chen Y; Liu L; Wu D
Front Immunol; 2021; 12():688215. PubMed ID: 34305920
[TBL] [Abstract][Full Text] [Related]
8. A subset of virus-specific CD161
Alsuliman A; Muftuoglu M; Khoder A; Ahn YO; Basar R; Verneris MR; Muranski P; Barrett AJ; Liu E; Li L; Stringaris K; Armstrong-James D; Shaim H; Kondo K; Imahashi N; Andersson B; Marin D; Champlin RE; Shpall EJ; Rezvani K
Blood; 2017 Feb; 129(6):740-758. PubMed ID: 27821506
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Th1/Th17 Functions of CD161+ CD8+ T Cells in Mucosal Tissues of Rhesus Macaques.
Rout N
PLoS One; 2016; 11(6):e0157407. PubMed ID: 27309719
[TBL] [Abstract][Full Text] [Related]
10. CD161(high)CD8+T cells bear pathogenetic potential in multiple sclerosis.
Annibali V; Ristori G; Angelini DF; Serafini B; Mechelli R; Cannoni S; Romano S; Paolillo A; Abderrahim H; Diamantini A; Borsellino G; Aloisi F; Battistini L; Salvetti M
Brain; 2011 Feb; 134(Pt 2):542-54. PubMed ID: 21216829
[TBL] [Abstract][Full Text] [Related]
11. CD161 Is Expressed in a Subset of T-Cell Prolymphocytic Leukemia Cases and Is Useful for Disease Follow-up.
Gilles SR; Yohe SL; Linden MA; Dolan M; Hirsch B; Grzywacz B
Am J Clin Pathol; 2019 Sep; 152(4):471-478. PubMed ID: 31305900
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer cells inhibits NK cell-mediated killing through LLT1-NKRP1A (CD161) interaction.
Mathew SO; Chaudhary P; Powers SB; Vishwanatha JK; Mathew PA
Oncotarget; 2016 Oct; 7(42):68650-68661. PubMed ID: 27626681
[TBL] [Abstract][Full Text] [Related]
13. CD161(+) T cells as predictive markers for acute graft-versus-host disease.
Lee SE; Lim JY; Yoon JH; Shin SH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Min CK
Biol Blood Marrow Transplant; 2015 Mar; 21(3):421-8. PubMed ID: 25543092
[TBL] [Abstract][Full Text] [Related]
14. Age and CD161 expression contribute to inter-individual variation in interleukin-23 response in CD8+ memory human T cells.
Shen H; Zhang W; Abraham C; Cho JH
PLoS One; 2013; 8(3):e57746. PubMed ID: 23469228
[TBL] [Abstract][Full Text] [Related]
15. A CD4+CD161+ T-Cell Subset Present in Unexposed Humans, Not Tb Patients, Are Fast Acting Cells That Inhibit the Growth of Intracellular Mycobacteria Involving CD161 Pathway, Perforin, and IFN-γ/Autophagy.
Yang R; Peng Y; Pi J; Liu Y; Yang E; Shen X; Yao L; Shen L; Modlin RL; Shen H; Sha W; Chen ZW
Front Immunol; 2021; 12():599641. PubMed ID: 33732233
[TBL] [Abstract][Full Text] [Related]
16. Induction of lectin-like transcript 1 (LLT1) protein cell surface expression by pathogens and interferon-γ contributes to modulate immune responses.
Germain C; Meier A; Jensen T; Knapnougel P; Poupon G; Lazzari A; Neisig A; Håkansson K; Dong T; Wagtmann N; Galsgaard ED; Spee P; Braud VM
J Biol Chem; 2011 Nov; 286(44):37964-37975. PubMed ID: 21930700
[TBL] [Abstract][Full Text] [Related]
17. Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples.
Di W; Fan W; Wu F; Shi Z; Wang Z; Yu M; Zhai Y; Chang Y; Pan C; Li G; Kahlert UD; Zhang W
Cancer Sci; 2022 Feb; 113(2):756-769. PubMed ID: 34881489
[TBL] [Abstract][Full Text] [Related]
18. Impact of Aging on the Frequency, Phenotype, and Function of CD161-Expressing T Cells.
van der Geest KSM; Kroesen BJ; Horst G; Abdulahad WH; Brouwer E; Boots AMH
Front Immunol; 2018; 9():752. PubMed ID: 29725326
[TBL] [Abstract][Full Text] [Related]
19. Characterization of alternatively spliced transcript variants of CLEC2D gene.
Germain C; Bihl F; Zahn S; Poupon G; Dumaurier MJ; Rampanarivo HH; Padkjær SB; Spee P; Braud VM
J Biol Chem; 2010 Nov; 285(46):36207-15. PubMed ID: 20843815
[TBL] [Abstract][Full Text] [Related]
20. Depletion of pro-inflammatory CD161(+) double negative (CD3(+)CD4(-)CD8(-)) T cells in AIDS patients is ameliorated by expansion of the γδ T cell population.
Singleterry WL; Henderson H; Cruse JM
Exp Mol Pathol; 2012 Feb; 92(1):155-9. PubMed ID: 22100877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]